Parth Mehrotra - Jul 5, 2022 Form 4 Insider Report for Privia Health Group, Inc. (PRVA)

Role
President and COO
Signature
/s/ Thomas Bartrum, as attorney-in-fact
Stock symbol
PRVA
Transactions as of
Jul 5, 2022
Transactions value $
-$1,117,312
Form type
4
Date filed
7/7/2022, 06:26 PM
Previous filing
Jun 23, 2022
Next filing
Jul 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRVA Common Stock, $0.01 par value per share Options Exercise $80K +40K +41.07% $2.00* 137K Jul 5, 2022 Direct
transaction PRVA Common Stock, $0.01 par value per share Sale -$57.1K -1.99K -1.45% $28.70 135K Jul 5, 2022 Direct F1, F2
transaction PRVA Common Stock, $0.01 par value per share Sale -$617K -21K -15.49% $29.41 114K Jul 5, 2022 Direct F1, F3
transaction PRVA Common Stock, $0.01 par value per share Sale -$478K -15.6K -13.63% $30.64 98.8K Jul 5, 2022 Direct F1, F4
transaction PRVA Common Stock, $0.01 par value per share Sale -$35.7K -1.14K -1.15% $31.36 97.7K Jul 5, 2022 Direct F1, F5
transaction PRVA Common Stock, $0.01 par value per share Sale -$9.75K -300 -0.31% $32.50 97.4K Jul 5, 2022 Direct F1, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRVA Stock Option (Right to Purchase) Options Exercise $0 -40K -2.52% $0.00 1.55M Jul 5, 2022 Common Stock 40K $2.00 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.00 to $28.99 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.02 to $29.99 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.02 to $30.98 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F5 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.07 to $31.95 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F6 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.43 to $32.54 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F7 Reflects stock options to purchase shares of common stock of the Issuer under the Plan. 1,312,132 of the stock options are fully vested and exercisable. 273,560 of the stock options will vest on October 29, 2022.